Improving Standard Therapies

Dr. Brad Nelson (2003 and 2004 Research Grants)

Dr. Brad Nelson’s research hopes to improve popular prostate cancer treatments like hormone therapy and radiation. In March 2007, he published a study that showed for the first time that, in addition to fighting cancer themselves, these therapies also stimulate the body’s own immune system to fight tumours.

Dr. Nelson identified 21 specific antigens that are released by prostate tumours and attacked by the immune system. He is now using these antigens to develop a drug that can improve the immune-friendly effects of radiation and hormone therapy. Ultimately, this drug – which would be given to men before treatment - could be a cost effective way of making therapy more effective and help men live longer.

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive